Liver Cancer
Machine-translated from Korean
5-Year Relative Survival
39.3%
Substantially above the US figure (about 22%, SEER) — the result of multidisciplinary care spanning transplant, resection and embolization.
Treatment Options
Transplant to targeted therapy
From living-donor transplant to RFA, the full stage-by-stage option set is coordinated within a single center.
Surveillance Program
High-risk: every 6 months
Decades of hepatitis-B management built standardized 6-month ultrasound and biomarker surveillance for high-risk patients.
Source Korea Central Cancer Registry (MOHW, 2017-2021) · US NCI SEER